Feds Kill Plan to Curb Medicare Advantage Overbilling After Industry Opposition
In 2014, CMS proposed a regulation to address Medicare Advantage overbilling but withdrew it. UnitedHealth faces allegations of defrauding Medicare over $2 billion, highlighting oversight concerns in the system.
Read original articleIn 2014, the Centers for Medicare & Medicaid Services (CMS) proposed a regulation aimed at curbing overbilling by Medicare Advantage insurers, which would have required these plans to identify and refund overpayments to the government. However, the proposal was withdrawn after significant pushback from the industry, with CMS officials citing pressure from stakeholders. This decision is now central to a civil fraud case against UnitedHealth Group, which is accused of defrauding Medicare of over $2 billion by improperly billing for additional diagnoses while ignoring unsupported charges. The Justice Department claims that UnitedHealth's practices led to inflated payments, as the company allegedly failed to delete invalid billing codes. UnitedHealth denies any wrongdoing, arguing that it should not be penalized for a rule that was never implemented. The case highlights ongoing concerns about the oversight of Medicare Advantage plans, which have seen rapid growth and are often criticized for exaggerating patient conditions to secure higher payments. Experts have noted that the CMS's reluctance to enforce stricter regulations reflects a broader issue of inadequate oversight in the face of powerful health insurers. The situation raises alarms about the potential misuse of taxpayer funds in the Medicare system.
- CMS proposed a regulation in 2014 to curb Medicare Advantage overbilling but withdrew it due to industry pressure.
- UnitedHealth Group faces allegations of defrauding Medicare of over $2 billion through improper billing practices.
- The case underscores ongoing concerns about the oversight of Medicare Advantage plans and their financial practices.
- Experts criticize CMS for lacking the enforcement needed to protect taxpayer funds from potential misuse.
- Medicare Advantage plans have grown significantly, now enrolling over 33 million members, raising scrutiny over their billing practices.
Related
The Opaque Industry Inflating Prices for Prescription Drugs
Pharmacy Benefit Managers (PBMs) like CVS Health, Cigna, and UnitedHealth Group are criticized for increasing prescription drug costs in the US. Despite claims of cost reduction, PBMs allegedly steer towards expensive drugs, charge high markups, and prioritize financial gains over patients. Lawmakers are scrutinizing their practices for potential price inflation and anticompetitive behavior.
200 people charged in $2.7B health care fraud crackdown
The Justice Department charged nearly 200 individuals in a $2.7 billion health care fraud crackdown. Cases involved scams targeting terminally ill patients, kickbacks for unnecessary treatments, and assets seized to prevent fleeing.
Change Healthcare starts sending data breach notifications after cyberattack
Change Healthcare notifies customers of a data breach exposing medical, payment, and personal data. The cyberattack in February disrupted healthcare operations. UnitedHealth faces criticism for delayed breach notifications.
The Mafia of Pharma Pricing
The Federal Trade Commission report exposes health care conglomerates, particularly pharmacy benefit managers (PBMs), for inflating drug prices and manipulating the market. PBMs' practices contribute to rising healthcare costs and may lead to potential lawsuits.
Judge Rules $400M Algorithmic System Illegally Denied People's Medicaid Benefits
A U.S. District Court judge ruled Tennessee's TennCare Connect system unlawfully denied Medicaid benefits due to errors, impacting thousands. The decision followed a class action lawsuit and calls for investigations into Deloitte.
- Many commenters express outrage over UnitedHealth's alleged fraud and call for legal action against the company.
- There is a consensus that the government's oversight and enforcement of Medicare billing practices are inadequate.
- Some commenters link the situation to broader concerns about corporate ethics and the influence of lobbyists on government decisions.
- Several individuals criticize the privatization of Medicare and its impact on patients, particularly those on disability.
- Comments highlight a perceived lack of accountability and virtue among large corporations in the U.S.
Hopefully that's in the offing given:
The 2014 decision by CMS, and events related to it, are at the center of a multibillion-dollar Justice Department civil fraud case against UnitedHealth Group pending in federal court in Los Angeles.
(From TFA.)
Kudos to the DoJ for the current case. I do hope they prevail and secure meaningful consequence.
But surely it can't really be true?
Could we have some kind of counter-news that celebrates the corporations that do things right, that encourage their employees to behave as upstanding members of society?
Your overpayment today funds your children's and grandchildren's more effective overpayments.
It's your legacy.
Sounds like the "what" is already properly illegal without needing to dictate the "how".
Not sure why they would care, otherwise.
Medical coding itself is already too complicated to make it easy to distinguish from those codes meant to increase payments and those that are legitimate payments.
I am on permanent disability and in the last three years there has been constant pressure for me to sign up and I always refuse. They want to switch me to more expensive meds when the generics work fine.
Medicare Advantage is just another transfer of wealth to the top.
>…But in May 2014, CMS dropped the idea without any public explanation. Newly released court depositions show that agency officials repeatedly cited concern about pressure from the industry…
> "Feds killed plan to curb Medicare Advantage overbilling after Industry opposition (2014)"
Related
The Opaque Industry Inflating Prices for Prescription Drugs
Pharmacy Benefit Managers (PBMs) like CVS Health, Cigna, and UnitedHealth Group are criticized for increasing prescription drug costs in the US. Despite claims of cost reduction, PBMs allegedly steer towards expensive drugs, charge high markups, and prioritize financial gains over patients. Lawmakers are scrutinizing their practices for potential price inflation and anticompetitive behavior.
200 people charged in $2.7B health care fraud crackdown
The Justice Department charged nearly 200 individuals in a $2.7 billion health care fraud crackdown. Cases involved scams targeting terminally ill patients, kickbacks for unnecessary treatments, and assets seized to prevent fleeing.
Change Healthcare starts sending data breach notifications after cyberattack
Change Healthcare notifies customers of a data breach exposing medical, payment, and personal data. The cyberattack in February disrupted healthcare operations. UnitedHealth faces criticism for delayed breach notifications.
The Mafia of Pharma Pricing
The Federal Trade Commission report exposes health care conglomerates, particularly pharmacy benefit managers (PBMs), for inflating drug prices and manipulating the market. PBMs' practices contribute to rising healthcare costs and may lead to potential lawsuits.
Judge Rules $400M Algorithmic System Illegally Denied People's Medicaid Benefits
A U.S. District Court judge ruled Tennessee's TennCare Connect system unlawfully denied Medicaid benefits due to errors, impacting thousands. The decision followed a class action lawsuit and calls for investigations into Deloitte.